CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,868 | -13.0% | 159,791 | 0.0% | 5.34% | -8.1% |
| Q2 2023 | $2,148 | -12.6% | 159,791 | +7.8% | 5.81% | -18.6% |
| Q1 2023 | $2,458 | -10.9% | 148,281 | 0.0% | 7.14% | -18.4% |
| Q4 2022 | $2,758 | -99.9% | 148,281 | 0.0% | 8.75% | +54.2% |
| Q3 2022 | $1,902,000 | +37.5% | 148,281 | -24.8% | 5.68% | +26.2% |
| Q2 2022 | $1,383,000 | -19.9% | 197,251 | -5.3% | 4.50% | +29.0% |
| Q1 2022 | $1,726,000 | +19.4% | 208,189 | -2.5% | 3.48% | +26.8% |
| Q4 2021 | $1,446,000 | +34.4% | 213,609 | +5.2% | 2.75% | +79.0% |
| Q3 2021 | $1,076,000 | +8.1% | 203,079 | +17.3% | 1.54% | +14.2% |
| Q2 2021 | $995,000 | -4.0% | 173,079 | -23.0% | 1.34% | +2.3% |
| Q1 2021 | $1,036,000 | +37.8% | 224,774 | -0.2% | 1.31% | -21.3% |
| Q4 2020 | $752,000 | +0.4% | 225,274 | -10.7% | 1.67% | -28.8% |
| Q3 2020 | $749,000 | -42.8% | 252,199 | -11.0% | 2.35% | -42.2% |
| Q2 2020 | $1,310,000 | +22.5% | 283,494 | +2.1% | 4.06% | -13.2% |
| Q1 2020 | $1,069,000 | +0.9% | 277,774 | -1.6% | 4.68% | +39.4% |
| Q4 2019 | $1,059,000 | -29.6% | 282,424 | -0.3% | 3.36% | -30.9% |
| Q3 2019 | $1,505,000 | +73.8% | 283,334 | +25.6% | 4.86% | +83.2% |
| Q2 2019 | $866,000 | -27.3% | 225,584 | -3.5% | 2.65% | -26.2% |
| Q1 2019 | $1,192,000 | +147.8% | 233,794 | -6.7% | 3.59% | +135.1% |
| Q4 2018 | $481,000 | -49.3% | 250,683 | 0.0% | 1.53% | -30.6% |
| Q3 2018 | $948,000 | +21.2% | 250,683 | 0.0% | 2.20% | +17.5% |
| Q2 2018 | $782,000 | +27.6% | 250,683 | -2.3% | 1.88% | +28.0% |
| Q1 2018 | $613,000 | -38.9% | 256,593 | 0.0% | 1.46% | -36.0% |
| Q4 2017 | $1,003,000 | +65.0% | 256,593 | +6.4% | 2.29% | +68.9% |
| Q3 2017 | $608,000 | -8.6% | 241,078 | 0.0% | 1.36% | -11.0% |
| Q2 2017 | $665,000 | +59.9% | 241,078 | -0.3% | 1.52% | +66.2% |
| Q1 2017 | $416,000 | -29.5% | 241,753 | -59.0% | 0.92% | -33.6% |
| Q4 2016 | $590,000 | -17.1% | 589,883 | -13.5% | 1.38% | -19.1% |
| Q3 2016 | $712,000 | +53.4% | 681,613 | 0.0% | 1.71% | +43.2% |
| Q2 2016 | $464,000 | -39.3% | 681,613 | 0.0% | 1.19% | -30.7% |
| Q1 2016 | $764,000 | +222.4% | 681,613 | +510.3% | 1.72% | +237.1% |
| Q4 2015 | $237,000 | -29.3% | 111,693 | 0.0% | 0.51% | -39.8% |
| Q3 2015 | $335,000 | -27.5% | 111,693 | 0.0% | 0.85% | -26.1% |
| Q2 2015 | $462,000 | +5.5% | 111,693 | 0.0% | 1.15% | -5.4% |
| Q1 2015 | $438,000 | +23.4% | 111,693 | -19.4% | 1.21% | +14.7% |
| Q4 2014 | $355,000 | -14.3% | 138,493 | -6.4% | 1.06% | -12.5% |
| Q3 2014 | $414,000 | -29.7% | 147,993 | -50.0% | 1.21% | +47.2% |
| Q2 2014 | $589,000 | +97.7% | 295,986 | +100.0% | 0.82% | -9.4% |
| Q1 2014 | $298,000 | +18.7% | 147,993 | 0.0% | 0.90% | +22.5% |
| Q4 2013 | $251,000 | -39.4% | 147,993 | 0.0% | 0.74% | -48.1% |
| Q3 2013 | $414,000 | +286.9% | 147,993 | 0.0% | 1.42% | +273.0% |
| Q2 2013 | $107,000 | – | 147,993 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |